Progressive Thymic Hyperplasia With Graves' Disease: A Case Report

Cureus. 2023 Aug 22;15(8):e43950. doi: 10.7759/cureus.43950. eCollection 2023 Aug.

Abstract

We treated a 36-year-old man with thymic hyperplasia complicated with Graves' disease. Thymic hyperplasia was observed on thoracic computed tomography (CT) three months after the onset of thyrotoxicosis symptoms. One month after thiamazole initiation, he displayed drug-induced liver injury and underwent a total thyroidectomy. Seven months after surgery, we observed a dramatic reduction of thymic size associated with normalizing the soluble interleukin-2 receptor (sIL-2R) levels. The rapid development of hyperplasia after the onset of thyrotoxicosis and the restoration in thymus volume after total thyroidectomy associated with suppression of sIL-2R, in this case, suggests the complexity of the pathogenesis of thymic hyperplasia in the thyrotoxicosis.

Keywords: graves’ disease; sil-2r; thiamazole; thymic hyperplasia; thyroidectomy.

Publication types

  • Case Reports